|
GRSF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.979400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.702200E-01 |
| Normal-vs-Stage2 |
3.522200E-01 |
| Normal-vs-Stage3 |
4.128400E-01 |
| Normal-vs-Stage4 |
1.627780E-01 |
| Stage1-vs-Stage2 |
2.740600E-01 |
| Stage1-vs-Stage3 |
3.444000E-01 |
| Stage1-vs-Stage4 |
1.705380E-01 |
| Stage2-vs-Stage3 |
1.158430E-01 |
| Stage2-vs-Stage4 |
4.872200E-02 |
| Stage3-vs-Stage4 |
5.647400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.122600E-01 |
| Normal-vs-AfricanAmerican |
2.311400E-01 |
| Normal-vs-Asian |
5.429200E-01 |
| Caucasian-vs-AfricanAmerican |
8.805600E-02 |
| Caucasian-vs-Asian |
8.929600E-01 |
| AfricanAmerican-vs-Asian |
1.018400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.629800E-01 |
| Normal-vs-Female |
9.255400E-01 |
| Male-vs-Female |
5.377000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.413000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.877000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.084600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.420800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.018400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.325800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.515800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.134000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.518800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.053600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.481420E-01 |
| Classical-VS-Follicular |
6.761400E-01 |
| Classical-VS-Other |
3.848600E-01 |
| Classical-VS-Normal |
7.201800E-01 |
| Tall-VS-Follicular |
2.960400E-01 |
| Tall-VS-Other |
9.003600E-01 |
| Tall-VS-Normal |
2.311200E-01 |
| Follicular-VS-Other |
5.631000E-01 |
| Follicular-VS-Normal |
9.359600E-01 |
| Other-VS-Normal |
5.827400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.822600E-01 |
| Normal-vs-N1 |
1.601810E-02 |
| N0-vs-N1 |
2.606100E-02 |
|
|
